TFS HealthScience hops into Australia to expand APAC operations
14 Mar 2024
Clinical Study
Preview
Source: FierceBiotech
TFS HealthScience plans to grow its footprint in other Asia-Pacific countries beyond Australia.
TFS HealthScience is growing Down Under, setting up a new operational base in Melbourne, Australia—the CRO's first official location in the Asia-Pacific (APAC) region.
“Australia’s expanding market aligns perfectly with our vision for growth and innovation,” TFS CEO Bassem Saleh, M.D., said in a March 11 press release. “This expansion enables us to better integrate into the APAC region and strengthens our commitment to delivering unparalleled clinical research solutions to our global network.”
TFS is an 800-employee, full-service CRO for pharmas and biotechs, with operations in ophthalmology, neurology, dermatology, oncology, internal medicine and more. It already had consultants and partner CROs in the APAC region prior to the establishment of its new base but will now be able to expand its site network. The company plans to grow its footprint in other APAC countries beyond Australia, according to the press release.
TFS operates in more than 40 countries, most recently adding Israel to its list through a partnership with GCP Clinical Studies.
Meanwhile, other CROs have been expanding their footprint in Australia recently as well; Alliance Pharma opened a bioanalytical lab in Brisbane in 2022, while Anatara Lifesciences and ObvioHealth inked a deal in 2021 for “siteless” clinical trials in Australia involving patients with irritable bowel syndrome. A 2016 report found that the country is attractive to early-stage CROs on account of its low tax status relative to the U.S.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.